Fujirebio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Japan · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1-8-1 Akasaka Akasaka Intercity Air, Min...Phone Number
+81 362790800Website
www.fujirebio.comRevenue
$405.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Fujirebio
Fujirebio Corporation is a global leader in the field of in vitro diagnostics, driving innovation and providing critical solutions that support healthcare providers and patients worldwide. The company specializes in biomarker discovery, diagnostic content development, and advanced in vitro diagnostic (IVD) technologies that power a wide range of tests on leading diagnostic platforms. By focusing on clinical evidence, research-driven innovation, and strategic global partnerships, Fujirebio ensures that next-generation diagnostic tools are accessible across multiple platforms, enabling healthcare professionals to deliver accurate and timely results regardless of the system being used.Explore more
Fujirebio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fujirebio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Fujirebio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Fujirebio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Fujirebio
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Fujirebio launches new products
Check out if Fujirebio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Fujirebio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Fujirebio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Fujirebio has new funding data
Recommended Actions
Reach out to Masked Content who joined Fujirebio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Fujirebio
Compare insights from companies similar to Fujirebio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fujirebio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fujirebio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fujirebio.
Fujirebio Tech Stack
A closer look at the technologies used by Fujirebio
Most Recent Scoops
Hiring Plans
Fujirebio has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: Salesforce. Areas of expertise include: Sales Forecasting, Sales Process, and Solution Selling.
Hiring Plans
Person-Based
Medical Research
Open Position
Hiring Plans
Fujirebio has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: SAP.
Hiring Plans
Open Position
Fujirebio News & Media
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
TOKYO & SUNNYVALE, Calif.--(BUSINESS WIRE)-- #IVD--Fujirebio, a leading innovator in in-vitro diagnostics, today announced a collaboration with Stanford Medicine (Location: Palo Alto, California, USA) to advance research and innovation in the field of infectious disease testing. This collaboration aims to accelerate the adoption of ultrasensitive immunoassays that incorporate single-molecule counting technology developed by Fujirebio’s Silicon Valley wholly-owned subsidiary, Fluxus, Inc. GreaterFujirebio Enhances Supply Chain Operations with Kinaxis
OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Fujirebio Inc., a Japanese multinational biotechnology company, is using Kinaxis and its AI-powered supply chain orchestration platform Maestro™ to enhance and optimize its supply chain operations. Fujirebio Inc., a consolidated subsidiary of Fujirebio Holdings Inc., is a global leader in the development, manufacturing and sales of clinical diagnostic reagents andFujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
TOKYO, Dec 23, 2024 - (JCN Newswire) - Fujirebio Holdings, Inc., a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., Ltd. announced today that they have entered into a memorandum of understanding for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. Fujirebio and Eisai have been conducting joint research on cerebrospinal fluid biomarkers related to Alzheimer’s disease (AD). The two companies have agreed toADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
GENT, Belgium & FREMONT, Calif.--(BUSINESS WIRE)-- #IVD--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies, today announced a partnership in the development of customized biomarker assay solutions using Alamar’s NULISA™ (Nucleic Acid Linked Immuno-Sandwich Assay) immunoassay platform and ARGO™ HT System. This collaboration aims to provide advanced
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Fujirebio
Sign Up For FreeTo access detailed company insights
Fujirebio Corporation is a global leader in the field of in vitro diagnostics, driving innovation and providing critical solutions that support healthcare providers and patients worldwide. The company specializes in biomarker discovery, diagnostic content development, and advanced in vitro diagnostic (IVD) technologies that power a wide range of te... Read More
